Jazz Pharmaceuticals
JAZZ
Jazz Pharmaceuticals (JAZZ) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $296.00 from $299.00 | Oct 8, 2026 |
| Truist Securities | Maintained | Buy | $286.00 from $281.00 | Oct 7, 2026 |
| Citigroup | Initiated Coverage | Buy | $325.00 | Sep 30, 2026 |
| Goldman Sachs | Maintained | Buy | $337.00 | Sep 24, 2026 |
| UBS | Maintained | Buy | $337.00 from $315.00 | Sep 11, 2026 |
| Barclays | Maintained | Overweight | $271.00 from $270.00 | Sep 10, 2026 |
| Needham | Maintained | Buy | $310.00 from $292.00 | Aug 26, 2026 |
| Truist Securities | Maintained | Buy | $281.00 from $264.00 | Aug 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $322.00 from $283.00 | Aug 26, 2026 |
| Deutsche Bank | Maintained | Buy | $300.00 from $287.00 | Aug 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $283.00 from $280.00 | Aug 11, 2026 |
| Baird | Maintained | Outperform | $280.00 from $252.00 | Aug 4, 2026 |
| Barclays | Maintained | Overweight | $270.00 from $260.00 | Aug 4, 2026 |
| Needham | Maintained | Buy | $292.00 from $282.00 | Aug 4, 2026 |
| Piper Sandler | Maintained | Overweight | $310.00 from $301.00 | Aug 4, 2026 |
| Morgan Stanley | Maintained | Overweight | $280.00 from $245.00 | Aug 4, 2026 |
| Wells Fargo | Maintained | Overweight | $300.00 from $285.00 | Aug 4, 2026 |
| TD Cowen | Maintained | Buy | $300.00 from $275.00 | Aug 4, 2026 |
| Truist Securities | Maintained | Buy | $264.00 from $254.00 | Aug 4, 2026 |
| JP Morgan | Maintained | Overweight | $276.00 from $265.00 | Aug 4, 2026 |
Frequently asked questions
What is the latest analyst rating on JAZZ?
On Oct 8, 2026, RBC Capital maintained Jazz Pharmaceuticals at Outperform with a price target of $296.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.